LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

W. Zeijlemaker, R. Meijer, A. Kelder, J. Carbaat-Ham, Y. Oussoren-brockhoff, S. Snel, D. Veldhuizen, W. Scholten, J. Maertens, D. Breems, T. Pabst, M. Manz, V. Van der Velden, J. Slomp, P. Valk, J. Cloos, B. Lowenberg, G. Ossenkoppele, G. J. Schuurhuis

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)7-8
JournalHaematologica
Volume102
Publication statusPublished - 26 Jun 2017

Cite this